EVGN (Evogene) Inventories, Raw Materials & Components: $0.00 Mil (As of Mar. 2026)


EVGN Evogene Ltd EVGN
34 GF Score
Price $0.44
GF Value $0.46
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Evogene Inventories, Raw Materials & Components?

Evogene EVGN +1.74% 34 Inventories, Raw Materials & Components is $0.00 Mil as of Mar. 2026. GuruFocus rates EVGN with a GF Score™ of 34/100 and a GF Value™ of $0.46 (Fairly Valued). The stock has 7 warning signs investors should review.

Evogene's inventories, raw materials & components for the quarter that ended in Mar. 2026 was $0.00 Mil.

Evogene Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Evogene's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evogene Inventories, Raw Materials & Components Chart

Evogene Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Evogene Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
EVGN
34GF Score
Evogene Ltd EVGN
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evogene Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of $0.00 Mil mean?
Evogene (EVGN) has a Inventories, Raw Materials & Components of $0.00 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Evogene and its competitors.
Is Evogene's Inventories, Raw Materials & Components too high?
Evogene's current Inventories, Raw Materials & Components is $0.00 Mil. Overall, Evogene has a GF Score™ of 34/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Evogene's Inventories, Raw Materials & Components compare to VRTX and REGN?
Evogene's Inventories, Raw Materials & Components of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Evogene and its competitors. Evogene's current Inventories, Raw Materials & Components is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evogene stock overvalued right now?
Based on GuruFocus' analysis, Evogene (EVGN) is currently considered Fairly Valued. The stock's GF Value™ is $0.46, compared to a current price of $0.44 — trading 4.6% below its estimated fair value. The current Inventories, Raw Materials & Components is $0.00 Mil. Evogene's overall GF Score™ is 34/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Evogene (EVGN), the current Inventories, Raw Materials & Components is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Evogene (EVGN) Overvalued in 2026?

Based on GuruFocus' analysis, Evogene stock appears to be undervalued. The current stock price of $0.44 is trading 4.6% below its estimated GF Value™ of $0.46. GuruFocus considers Evogene to be Fairly Valued.

Key valuation signals for EVGN:

  • Inventories, Raw Materials & Components: $0.00 Mil
  • GF Value™: $0.46 vs. price of $0.44 (4.6% below fair value)
  • GF Score™: 34/100 with 7 warning signs

No single metric tells the full story. See the EVGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Evogene Business Description

Other Exchanges EVGN:Israel
Address 13 Gad Feinstein Street, Park Rehovot, Ness Ziona, Rehovot, ISR, 7638517
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.
34GF Score

Get the complete analysis for EVGN

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.44
Price
$0.46
GF Value